A seven-day pilot study of 40 women found that Basis supplementation correlated with self-reported reductions of 50% or more in hot flashes, bloating, and sleep disruption, alongside a statistically significant shift in estradiol-to-estrone ratio favoring estradiol dominance. The mechanism appears linked to NAD+ metabolism and estrogen balance during the menopausal transition.
Key Points
- 50% reduction in hot flashes, bloating, poor sleep within seven days
- Significant increase in estradiol-to-estrone ratio (p<0.01) after supplementation
- Identified previously unreported NAD+ metabolite in estrogen metabolism
Longevity Analysis
The menopausal transition involves profound shifts in hormonal signaling, thermodynamic regulation, and sleep architecture—three interconnected systems that deteriorate rapidly without intervention. This pilot data suggests that NAD+ elevation may modulate the estrogen metabolic pathway toward a more favorable ratio, potentially stabilizing multiple downstream systems simultaneously. The seven-day timeline is notably compressed, warranting scrutiny in larger controlled trials, but the mechanistic signal (estradiol-to-estrone rebalancing) points toward a pathway distinct from exogenous hormone replacement. The identification of a novel NAD+ metabolite expands understanding of how cellular energy metabolism intersects with reproductive endocrinology during aging.
Original published by LT Wire.